HHS Says In 2025, All People With Medicare Part D Will Benefit From A $2,000 Cap On Annual Out-Of-Pocket Prescription Drug Costs
$CL
$CLOV
$CNC
$CVS
Package Goods/Cosmetics
Consumer Discretionary
Medical Specialities
Health Care
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 10/28/2024 | $105.00 → $101.00 | Buy → Hold | Stifel | |
| 10/17/2024 | Buy → Hold | HSBC Securities | ||
| 10/11/2024 | $675.00 | Overweight | KeyBanc Capital Markets | |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | ||
| 10/10/2024 | $63.00 → $82.00 | Equal Weight → Overweight | Barclays | |
| 10/8/2024 | $308.00 | Mkt Perform → Outperform | Bernstein | |
| 10/7/2024 | $402.00 → $261.00 | Buy → Hold | TD Cowen | |
| 10/7/2024 | $519.00 → $253.00 | Buy → Hold | Jefferies |
Reports 3Q24 earnings per share (EPS) of $3.98 on a GAAP basis, Adjusted EPS of $4.16; reports YTD 2024 EPS of $15.72 on a GAAP basis, $18.35 on an Adjusted basis Updates FY 2024 EPS guidance to 'at least $12.89' on a GAAP basis, 'at least $16.00' on an Adjusted basis; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 40,000 to now anticipate annual growth of approximately 265,000, or approximately 5 percent Publishes prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00 a.m. ET question and answer session to discuss its financial results for
Colgate-Palmolive Company (NYSE:CL): Net sales increased 2.4%; Organic sales* increased 6.8% GAAP EPS increased 5% to $0.90; Base Business EPS* increased 6% to $0.91 GAAP Gross profit margin increased 260 basis points to 61.1%; Base Business Gross profit margin* increased 270 basis points to 61.3% Net cash provided by operations was $2,838 million for the first nine months of 2024 Colgate's leadership in toothpaste continued with its global market share at 41.6% year to date Colgate's leadership in manual toothbrushes continued with its global market share at 32.3% year to date The Company updated its financial guidance for full year 2024 Third Quarter Total Company Result
-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024.Premium and service revenues of $36.9 billion in the third quarter of 2024.Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023.Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024.ST. LOUIS, Oct. 25, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the
The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso
Stifel downgraded Colgate-Palmolive from Buy to Hold and set a new price target of $101.00 from $105.00 previously
HSBC Securities downgraded UnitedHealth from Buy to Hold
KeyBanc Capital Markets initiated coverage of UnitedHealth with a rating of Overweight and set a new price target of $675.00
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 5 years by 4.56% on an annualized basis producing an average annual return of 17.03%. Currently, UnitedHealth Group has a market capitalization of $515.19 billion. Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 5 years ago, it would be worth $2,205.30 today based on a price of $559.75 for UNH at the time of writing. UnitedHealth Group's Performance Over Last 5 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automa
SC 13G/A - Elevation Oncology, Inc. (0001783032) (Subject)
SC 13G - Elevation Oncology, Inc. (0001783032) (Subject)
SC 13D/A - Elevation Oncology, Inc. (0001783032) (Subject)
ST. LOUIS, Nov. 1, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Buckeye Health Plan (Buckeye), has been selected by the Ohio Department of Medicaid (ODM) to continue providing Medicare and Medicaid services for dually eligible individuals through a Fully Integrated Dual Eligible Special Needs Plan (FIDE SNP). FIDE SNPs fully integrate care for dually eligible beneficiaries under a single managed care organization, allowing enrollees to receive all of their medical, behavioral and long-term services and supports through one plan.
Ten years after full ACA implementation, eHealth report highlights gap between enrollees who receive subsidies and those who don't AUSTIN, Texas, Oct. 30, 2024 /PRNewswire/ -- The Affordable Care Act (ACA) was fully implemented ten years ago in 2014, but with open enrollment just around the corner, enrollees are split on the law's success, according to original research released today by eHealth Inc. (NASDAQ:EHTH) (eHealth.com), a leading online private health insurance marketplace. In a poll of more than 300 ACA plan enrollees, eHealth found a significant divide between those who receive government subsidies and those who do not. Sixty-six percent (66%) of those receiving federal subsidies
The addition of Advocate Health Care to the Ambetter of Illinois provider network offers its members expanded access to the health system's high-quality healthcare CHICAGO, Oct. 30, 2024 /PRNewswire/ -- Ambetter of Illinois (Ambetter), a product offered by Centene Corporation (NYSE:CNC), and managed locally by Meridian Health Plan of Illinois, Inc. (Meridian), announced today the addition of Advocate Health Care to its network, which will further increase members' access to quality healthcare in the Chicagoland area. Ambetter members can now receive care at any of Advocate's 11 hospitals and 300 sites of care in Illinois, with 6,500 physicians, and 11,000 nurses. Ambetter provides insurance
4 - eHealth, Inc. (0001333493) (Issuer)
4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
4 - eHealth, Inc. (0001333493) (Issuer)
3 - HUMANA INC (0000049071) (Issuer)
3 - GoHealth, Inc. (0001808220) (Issuer)
4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Humana (NYSE:HUM), has joined the firm as venture partner. Bruce will play a pivotal role at Define, leveraging his invaluable experience scaling companies and fostering innovation within private startups, mid-size companies, and the Fortune 50. He will partner closely with Define founders to scale their businesses and become category-defining companie
Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, R.I., Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped down from her position in agreement with the company's Board of Directors. Joyner also joined the Board of Directors. In addition, current Chairman of the Board, Roger Farah, will now be Executive Chairman.
CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t
8-K - eHealth, Inc. (0001333493) (Filer)
10-Q - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)